PAPER Velmeshev D, Schirmer L, Jung D, Haeussler M, Perez Y, Mayer S, Bhaduri A, Goyal N, Rowitch DH, Kriegstein AR

Single-cell genomics identifies cell type-specific molecular changes in autism.

Science. 2019 May 17;364(6441):685-689. PubMed: 31097668

Priya Gami-Patel

Verena Zyka

University of Cambridge
Cambridge, United Kingdom

PAPER Benavente KS, Palmer RF, Royall DR

Serum Adiponectin is Related to Dementia.

J Gerontol A Biol Sci Med Sci. 2019 Apr 25; PubMed: 31112230

PAPER Low A, Lim L, Lim L, Wong B, Silva E, Ng KP, Kandiah N

Construct validity of the Visual Cognitive Assessment Test (VCAT)-a cross-cultural language-neutral cognitive screening tool.

Int Psychogeriatr. 2019 May 21;:1-9. PubMed: 31111797

PAPER Ding XL, Lei P

Plasma Replacement Therapy for Alzheimer's Disease.

Neurosci Bull. 2019 May 20; PubMed: 31111428

PAPER D'Arrigo JS

Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood⁻Brain Barrier.

Biomimetics (Basel). 2018 Mar 7;3(1) PubMed: 31105226

PAPER Mastwyk M, Barac AM, Radler M, Sgambellone R, Pather Lowen V, Mitchell N, Zisis G, Cleon Rowe C, Louis Masters C

Science media-the best way to reach the target audience for a pre-clinical AD study.

Int Psychogeriatr. 2019 May 21;:1-2. PubMed: 31111805

PAPER Fadayevatan R, Alizadeh-Khoei M, Nourbakhsh F, Sharifi F, Hormozi S, Taati F, Fakhrzadeh H, Aminalroaya R

Validity and reliability of Bayer Activities of Daily Living (Bayer- ADL) scale in the Iranian elderly dementia population: Is there distinguish between illiterate and literate demented in functional dependency?

Appl Neuropsychol Adult. 2019 May 21;:1-11. PubMed: 31111745

PAPER Jin Y, Sun Y, Chen Y, Lei J, Wei G

Molecular dynamics simulations reveal the mechanism of graphene oxide nanosheet inhibition of Aβ1-42 peptide aggregation.

Phys Chem Chem Phys. 2019 Jun 7;21(21):10981-10991. Epub 2019 May 21 PubMed: 31111835

PAPER Liebsch F, Kulic L, Teunissen C, Shobo A, Ulku I, Engelschalt V, Hancock MA, van der Flier WM, Kunach P, Rosa-Neto P, Scheltens P, Poirier J, Saftig P, Bateman RJ, Breitner J, Hock C, Multhaup G

Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression.

Nat Commun. 2019 May 20;10(1):2240. PubMed: 31110178

PAPER Kramarow EA, Tejada-Vera B

Dementia Mortality in the United States, 2000-2017.

Natl Vital Stat Rep. 2019 Mar;68(2):1-29. PubMed: 31112120

PAPER Hicks AJ, James AC, Spitz G, Ponsford JL

Traumatic Brain Injury as a Risk Factor for Dementia and Alzheimer Disease: Critical Review of Study Methodologies.

J Neurotrauma. 2019 Aug 1; PubMed: 31111768

PAPER Yatawara C, Lee D, Ng KP, Chander R, Ng D, Ji F, Shim HY, Hilal S, Venketasubramanian N, Chen C, Zhou J, Kandiah N

Mechanisms Linking White Matter Lesions, Tract Integrity, and Depression in Alzheimer Disease.

Am J Geriatr Psychiatry. 2019 Sep;27(9):948-959. Epub 2019 Apr 18 PubMed: 31109898

PAPER Gaynor LS, Curiel Cid RE, Penate A, Rosselli M, Burke SN, Wicklund M, Loewenstein DA, Bauer RM

Visual Object Discrimination Impairment as an Early Predictor of Mild Cognitive Impairment and Alzheimer's Disease.

J Int Neuropsychol Soc. 2019 Aug;25(7):688-698. PubMed: 31111810